Abbott Laboratories (XSWX:ABT) Other Current Liabilities: CHF0 Mil (As of Mar. 2026)


XSWX:ABT Abbott Laboratories XSWX:ABT
80 GF Score
Price CHF74.50
GF Value CHF105.05
View Full Analysis

What is Abbott Laboratories Other Current Liabilities?

Abbott Laboratories XSWX:ABT 80 Other Current Liabilities is CHF0 Mil as of Mar. 2026. GuruFocus rates XSWX:ABT with a GF Score™ of 80/100 and a GF Value™ of CHF105.05.

Abbott Laboratories's other current liabilities for the quarter that ended in Mar. 2026 was CHF0 Mil.

Abbott Laboratories's quarterly other current liabilities declined from Sep. 2025 (CHF0 Mil) to Dec. 2025 (CHF-0 Mil) but then increased from Dec. 2025 (CHF-0 Mil) to Mar. 2026 (CHF0 Mil).

Abbott Laboratories's annual other current liabilities stayed the same from Dec. 2023 (CHF0 Mil) to Dec. 2024 (CHF0 Mil) but then declined from Dec. 2024 (CHF0 Mil) to Dec. 2025 (CHF-0 Mil).

Abbott Laboratories Other Current Liabilities Related Terms

Abbott Laboratories Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories Other Current Liabilities Chart

Abbott Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.00 0.00 0.00 -0.00

Abbott Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 0.00 0.00 -0.00 0.00
XSWX:ABT
80GF Score
Abbott Laboratories XSWX:ABT
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of CHF0 Mil mean?
Abbott Laboratories (XSWX:ABT) has a Other Current Liabilities of CHF0 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Abbott Laboratories.
Is Abbott Laboratories' Other Current Liabilities too high?
Abbott Laboratories' current Other Current Liabilities is CHF0 Mil. Overall, Abbott Laboratories has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' Other Current Liabilities compare to SYK and MDT?
Abbott Laboratories' Other Current Liabilities of CHF0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Abbott Laboratories. Abbott Laboratories's current Other Current Liabilities is CHF0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Abbott Laboratories (XSWX:ABT) has a current Other Current Liabilities of CHF0 Mil. The stock's GF Value™ is CHF105.05, compared to a current price of CHF74.50 — trading 29.1% below its estimated fair value. The current Other Current Liabilities is CHF0 Mil. Abbott Laboratories' overall GF Score™ is 80/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Abbott Laboratories (XSWX:ABT), the current Other Current Liabilities is CHF0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (XSWX:ABT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of CHF74.50 is trading 29.1% below its estimated GF Value™ of CHF105.05.

Key valuation signals for XSWX:ABT:

  • Other Current Liabilities: CHF0 Mil
  • GF Value™: CHF105.05 vs. price of CHF74.50 (29.1% below fair value)
  • GF Score™: 80/100

No single metric tells the full story. See the XSWX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
80GF Score

Get the complete analysis for XSWX:ABT

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF74.50
Price
CHF105.05
GF Value